-
Medical journals
- Career
Cardiology Review - Issue 3/2017
152Cardiovascular risk stratification and new serum lipid target levelsE. Tůmová, M. Vráblík
157Management of dyslipidaemias in specific patient groupsM. Vaclová, M. Vráblík, R. Češka
161Statin intolerance – finding practical solutionsM. Šnejdrlová
165168Is heart failure with preserved ejection fraction a serious illness?J. Murín, M. Macháčová, R. Compagnon, J. Bulas, M. Wawruch
172177Infective EndocarditisM. Tesák, J. Pařenica, E. Míšková
183Catheter ablation in atrial fibrillation and direct anticoagulantsJ. Špinar, R. Lábrová
187Thirty years of renin-angiotensin-aldosterone system inhibition in chronic heart failureJ. Vítovec, J. Špinar, L. Špinarová
195SGLT2 inhibitors (gliflozins) antidiabetics, antihypertensives or drugs for heart failure?J. Špinar, J. Vítovec, L. Špinarová
201Zoletorv – pharmacological profileB. Nussbaumerová
205Educational activities of nurses in patients after myocardial infarction – a reviewJ. Doležel, D. Jarošová
Cardiology Review
2017 Issue 3
Most read in this issue- SGLT2 inhibitors (gliflozins) antidiabetics, antihypertensives or drugs for heart failure?
- Cardiovascular risk stratification and new serum lipid target levels
- Statin intolerance – finding practical solutions
- Infective Endocarditis
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career